Skip to main content
Erschienen in: Journal of Contemporary Psychotherapy 2/2019

03.08.2018 | Original Paper

Successful Treatment of Halitophobia with Cognitive Behavioural Therapy: A Case Study

verfasst von: Jihed Mrizak, Uta Ouali, Amal Arous, Lamia Jouini, Rania Zaouche, Aroua Rebaï, Haifa Zalila

Erschienen in: Journal of Contemporary Psychotherapy | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Halitophobia is a condition characterized by an excessive preoccupation with the belief of having halitosis. Cognitive Behavioural Therapy (CBT) was successfully used to treat a man in his 20 s who presented with important anxiety, avoidance and safety behaviours, isolation, and depressed mood. Progressive in-vivo exposure to fearful situations with the systematic prevention of avoidance and safety behaviours resulted in a significant improvement in the patient’s anxiety and depression levels. This case suggests that CBT techniques, usually performed in anxiety disorders and in obsessive–compulsive disorder, can be adapted to halitophobia.
Literatur
Zurück zum Zitat American Psychiatric Association, A. D., A. P. S. M. T. F. (2013). Diagnostic and statistical manual of mental disorders. (5th ed.). Washington, DC: APACrossRef American Psychiatric Association, A. D., A. P. S. M. T. F. (2013). Diagnostic and statistical manual of mental disorders. (5th ed.). Washington, DC: APACrossRef
Zurück zum Zitat Kazdin, A. E. (1981). Drawing valid inferences from case studies. Journal of Consulting and Clinical Psychology, 49, 183–192.CrossRefPubMed Kazdin, A. E. (1981). Drawing valid inferences from case studies. Journal of Consulting and Clinical Psychology, 49, 183–192.CrossRefPubMed
Zurück zum Zitat Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988). The Hamilton Anxiety Scale: Reliability, validity and sensitivity to change in anxiety and depressive disorders. Journal of Affective Disorders, 14, 61–68.CrossRefPubMed Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988). The Hamilton Anxiety Scale: Reliability, validity and sensitivity to change in anxiety and depressive disorders. Journal of Affective Disorders, 14, 61–68.CrossRefPubMed
Zurück zum Zitat McLean, C. P., Van Meter, P. E., Carpenter, J. K., Simpson, H. B., Foa, E. B. (2015). Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies. The Journal of Clinical Psychiatry, 76, 1555–2101.CrossRef McLean, C. P., Van Meter, P. E., Carpenter, J. K., Simpson, H. B., Foa, E. B. (2015). Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies. The Journal of Clinical Psychiatry, 76, 1555–2101.CrossRef
Zurück zum Zitat Ong, C. W., Clyde, J. W., Bluett, E. J., Levin, M. E., & Twohig, M. P. (2016). Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say? Journal of Anxiety Disorders, 40, 1873–7897.CrossRef Ong, C. W., Clyde, J. W., Bluett, E. J., Levin, M. E., & Twohig, M. P. (2016). Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say? Journal of Anxiety Disorders, 40, 1873–7897.CrossRef
Zurück zum Zitat Rowa, K., Antony, M. M., & Swinson, R. P. (2007). Exposure and response prevention. In M. M. Antony, C. Purdon & L. J. Summerfeldt (Eds.), Psychological treatment of obsessive–compulsive disorder: Fundamentals and beyond (pp. 79–109). Washington, DC: American Psychological Association. https://doi.org/10.1037/11543-004.CrossRef Rowa, K., Antony, M. M., & Swinson, R. P. (2007). Exposure and response prevention. In M. M. Antony, C. Purdon & L. J. Summerfeldt (Eds.), Psychological treatment of obsessive–compulsive disorder: Fundamentals and beyond (pp. 79–109). Washington, DC: American Psychological Association. https://​doi.​org/​10.​1037/​11543-004.CrossRef
Zurück zum Zitat Toyofuku, A., Miyagi, U. G., Tone, T., Kikuta, K., Miyako, T. H (2001). The efficacy of fluvoxamine for “halitophobia”. Jpn J Psychosom, 16, 81–85. Toyofuku, A., Miyagi, U. G., Tone, T., Kikuta, K., Miyako, T. H (2001). The efficacy of fluvoxamine for “halitophobia”. Jpn J Psychosom, 16, 81–85.
Zurück zum Zitat Yaegaki, K., & Coil, J. M. (2000). Examination, classification, and treatment of halitosis; Clinical perspectives. Journal of Canadian Dental Association, 66, 257–261. Yaegaki, K., & Coil, J. M. (2000). Examination, classification, and treatment of halitosis; Clinical perspectives. Journal of Canadian Dental Association, 66, 257–261.
Metadaten
Titel
Successful Treatment of Halitophobia with Cognitive Behavioural Therapy: A Case Study
verfasst von
Jihed Mrizak
Uta Ouali
Amal Arous
Lamia Jouini
Rania Zaouche
Aroua Rebaï
Haifa Zalila
Publikationsdatum
03.08.2018
Verlag
Springer US
Erschienen in
Journal of Contemporary Psychotherapy / Ausgabe 2/2019
Print ISSN: 0022-0116
Elektronische ISSN: 1573-3564
DOI
https://doi.org/10.1007/s10879-018-9398-7

Weitere Artikel der Ausgabe 2/2019

Journal of Contemporary Psychotherapy 2/2019 Zur Ausgabe